The Scotts Miracle-Gro Company
SMG
$60.06
+1.13%
The Scotts Miracle-Gro Company is the largest purveyor of home lawn and gardening products in the United States, operating within the Agricultural Inputs industry. Its competitive identity is that of a dominant market leader with a portfolio of well-recognized consumer brands including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat. The current investor narrative is centered on a strategic turnaround and portfolio rationalization, highlighted by the recent divestiture of its Hawthorne Gardening subsidiary, which signals a refocus on the core, higher-margin consumer business and a concerted effort to reduce debt and improve financial flexibility.…
SMG
The Scotts Miracle-Gro Company
$60.06
Related headlines
SMG 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Scotts Miracle-Gro Company's 12-month outlook, with a consensus price target around $78.08 and implied upside of +30.0% versus the current price.
Average Target
$78.08
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$48 - $78
Analyst target range
Analyst coverage for SMG is very limited, with only two analysts providing estimates, indicating insufficient coverage for a robust consensus. The available data shows an estimated EPS average of $7.86 for the coming period, but no consensus price target, recommendation, or target range is provided in the dataset. This lack of coverage typically signifies limited institutional interest, which can be characteristic of a company undergoing a significant transition or facing complex financials; it often leads to higher stock price volatility and less efficient price discovery as the investment story is not widely disseminated or debated among the analyst community.
Bulls vs Bears: SMG Investment Factors
The investment debate for SMG is a classic tension between a promising strategic turnaround and a perilous financial foundation. The bull case is supported by strong peak-season cash generation, an improving revenue trajectory, and a strategic refocus that could unlock value. However, the bear case presents overwhelming evidence of financial distress, with a severely leveraged balance sheet and extreme earnings volatility that pose existential risks. Currently, the bearish evidence carries more weight due to the quantifiable, structural financial risks embedded in the negative equity and high debt burden. The single most important tension is whether the company's robust seasonal free cash flow can sustainably service and reduce its massive debt load before an economic or operational setback triggers a liquidity crisis.
Bullish
- Strong Peak Season Profitability: The company demonstrates its ability to generate substantial profits during its core selling seasons, with Q2 and Q3 of fiscal 2025 delivering net income of $217.5M and $149.1M, respectively. This validates the underlying business model's health when not in a seasonal trough.
- Robust Free Cash Flow Generation: Despite quarterly losses, SMG generated $358.1M in trailing twelve-month free cash flow. This provides critical liquidity to service its debt and fund operations, supporting the ongoing strategic turnaround.
- Strategic Refocus via Hawthorne Divestiture: The recent sale of the Hawthorne Gardening subsidiary, as per the April 2026 news, signals a disciplined pivot back to the higher-margin core consumer business. This move is central to the company's stated goal of reducing debt and improving financial flexibility.
- Attractive Forward Valuation: The stock trades at a forward P/E of 13.09x, a significant discount to its trailing P/E of 22.59x. This implies the market is pricing in a substantial earnings recovery, with the forward multiple suggesting a more reasonable valuation if turnaround goals are met.
Bearish
- Severely Leveraged Balance Sheet: The company's financial structure is precarious, with a debt-to-equity ratio of -6.66 and a negative Return on Equity of -40.62%. These figures reflect significant accumulated deficits and a high degree of financial risk that constrains strategic options.
- Extreme Earnings Volatility & Seasonality: Financial performance is wildly inconsistent, swinging from a Q1 2026 net loss of $125M to a Q2 2025 profit of $217.5M. This deep seasonality and volatility make the stock difficult to value and predict, especially for short-term investors.
- High Beta & Recent Underperformance: With a beta of 1.92, SMG is nearly twice as volatile as the market. It has significantly underperformed recently, with a 1-month relative strength of -8.82% versus the S&P 500, indicating heightened sensitivity to market downturns and weak near-term momentum.
- Limited Analyst Coverage & Visibility: Only two analysts cover the stock, and no consensus price target is available. This lack of institutional scrutiny leads to less efficient price discovery and higher volatility, as the investment thesis is not widely validated.
SMG Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 15.67% 1-year price change, but is currently experiencing a near-term pullback. With a current price of $61.72, it is trading at approximately 48% of its 52-week range ($52.00 to $72.35), positioning it closer to the midpoint, which suggests a consolidation phase after a significant rally. Recent momentum has turned negative, with the stock down 3.89% over the past three months and showing a 1-month relative strength of -8.82% versus the S&P 500, indicating significant short-term underperformance. This divergence from the longer-term uptrend could signal a healthy correction or a pause as the stock digests its prior gains, especially given its high beta of 1.92, which implies it is nearly twice as volatile as the broader market. Key technical support is clearly defined at the 52-week low of $52.00, while resistance sits at the recent high of $72.35; a decisive breakout above resistance would confirm the resumption of the primary uptrend, whereas a breakdown below $52 would invalidate the bullish structure and likely trigger further selling.
Beta
1.86
1.86x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$52-$72
Price range past year
Annual Return
+7.0%
Cumulative gain past year
| Period | SMG Return | S&P 500 |
|---|---|---|
| 1m | -6.0% | +10.4% |
| 3m | -7.2% | +5.5% |
| 6m | +6.3% | +8.0% |
| 1y | +7.0% | +28.4% |
| ytd | +1.1% | +6.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SMG Fundamental Analysis
Revenue is highly seasonal and currently in a cyclical trough, with the most recent Q1 2026 revenue of $354.4 million reflecting a 14.97% year-over-year decline, which is an improvement from the deeper 24.8% decline in the prior-year Q1. The multi-quarter trend shows the business is heavily weighted toward the spring and summer seasons, with Q2 and Q3 historically generating the bulk of annual sales and profits. The company is currently unprofitable on a quarterly basis, posting a Q1 2026 net loss of $125 million and a gross margin of 25.03%, which is compressed from the trailing twelve-month gross margin of 30.59% due to seasonal inefficiencies and product mix. The trajectory toward annual profitability is evident, as the company generated positive net income of $149.1 million and $217.5 million in Q3 and Q2 of fiscal 2025, respectively, demonstrating its ability to achieve strong margins during its peak selling periods. The balance sheet carries significant financial risk, with a negative debt-to-equity ratio of -6.66 and a negative Return on Equity of -40.62%, both artifacts of accumulated deficits; however, the company generated robust trailing twelve-month free cash flow of $358.1 million and maintains a current ratio of 1.27, providing near-term liquidity to manage its obligations.
Quarterly Revenue
$354400000.0B
2025-12
Revenue YoY Growth
-0.14%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$358099999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SMG Overvalued?
Given the company's positive trailing twelve-month net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 22.59x, which is below the forward PE of 13.09x, indicating the market expects a significant recovery in earnings over the next year. Compared to sector averages, the valuation presents a mixed picture; the trailing PE of 22.59x is not directly comparable without a provided industry average, but the Price-to-Sales ratio of 0.96x suggests the market is valuing the company at less than one times revenue, which could be considered modest for a market leader. Historically, the stock's own valuation has been extremely volatile, with its trailing PE ratio swinging from deeply negative figures to over 20x in recent quarters; the current level of 22.59x is near the higher end of its observable positive range, suggesting the market is pricing in a recovery but not at peak optimism.
PE
22.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -45x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's leveraged balance sheet. The negative debt-to-equity ratio of -6.66 indicates equity has been eroded by accumulated losses, meaning the company is technically insolvent on a book-value basis. While TTM free cash flow of $358.1M provides a lifeline, the business model's extreme seasonality—evidenced by a Q1 net loss of $125M—creates cash flow timing mismatches that could strain liquidity if the peak seasons underperform. Furthermore, the company's valuation and solvency are entirely dependent on a return to sustained annual profitability, which is not guaranteed.
Market & Competitive Risks are elevated by the stock's high volatility and valuation uncertainty. With a beta of 1.92, SMG will amplify any broader market downturn. Trading at a trailing P/E of 22.59x, which is at the higher end of its recent positive range, the stock has limited room for multiple expansion and is vulnerable to compression if earnings recovery is delayed. The lack of analyst coverage (only 2 analysts) exacerbates this, leading to potential mispricing and sharp reactions to news. While the divestiture of Hawthorne reduces complexity, it also removes a growth segment, increasing reliance on the mature, cyclical core lawn and garden market.
Worst-Case Scenario involves a combination of a weaker-than-expected spring selling season and a broader economic slowdown that curbs consumer discretionary spending on lawn care. This would lead to a significant earnings miss in Q2/Q3, triggering a covenant breach or liquidity crunch given the high debt load. Investor confidence would collapse, leading to a rapid re-rating. The realistic downside is to the 52-week low of $52.00, which represents a decline of approximately 16% from the current price of $61.72. In a more severe crisis of confidence, the stock could test levels below $50, implying a potential loss of 20% or more.